Stock overview
Trevi Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
TREVI THERAPEUTICS INC (TRVI) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $14.41
- · TRVI
- Tracked holders
- 2 funds
- Latest available 13F per fund
TRVI · USD
Price
$14.41
-$3.54
(-19.72%)
over selected range
Close · Sep 25, 2026
Market closed
23 stored daily closes
$14.41
Sep 25, 2026
- Range low
- $14.41
- Range high
- $17.96
- Observations
- 23
- Session date
- Sep 25, 2026
Aug 25, 2026–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Viking Global Investors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −52% 26'Q2 | $28,807,611 | 0.08% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +15% 26'Q2 | $1,379,690 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market